as on November 26, 2025 at 2:29 am IST
Day's Low
Day's High
6.25%
Downside
3.91%
Upside
52 Week's Low
52 Week's High
35.94%
Downside
165.63%
Upside
Check Verrica Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$40.0M
EPS (TTM)
-0.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.2
Industry PE ratio
-0.4356168831168831
PEG Ratio
0EBITDA
-15.0M
Revenue (TTM)
30.8M
Profit Margin
-84.38%
Return On Equity TTM
-1546.58%
Track how Verrica Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Verrica Pharmaceuticals Inc in the last 5 years
Lowest (-121.44x)
June 30, 2023
Today (-1.20x)
November 25, 2025
Industry (-0.44x)
November 25, 2025
Highest (-5.57x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.20x
Compare market cap, revenue, PE, and other key metrics of Verrica Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $40.0M | -95.01% | -1.2 | -84.38% | |
| BUY | $44.1B | 436.37% | -16.34 | -264.83% | |
| BUY | $57.7B | 246.14% | 1407.68 | 1.36% | |
| BUY | $109.4B | 94.41% | 30.03 | 31.35% | |
| BUY | $80.1B | 49.8% | 18.11 | 32.13% |
The Verrica Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Verrica Pharmaceuticals Inc investment value today
Current value as on today
₹57,470
Returns
Returns from Verrica Pharmaceuticals Inc Stock
Dollar Returns*
₹5,805 (+5.81%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Verrica Pharmaceuticals Inc. Average target price of $16.33
Get share price movements and forecasts by analysts on Verrica Pharmaceuticals Inc.
What analysts predicted
68.65%UPSIDE
Target Price
$16.33
Current Price
$5.12
Analyzed by
12 Analysts
Target
$16.33
Verrica Pharmaceuticals Inc target price $16.33, a slight upside of 68.65% compared to current price of $5.12. According to 12 analysts rating.
Search interest for Verrica Pharmaceuticals Inc Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:52% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 5 quarters, -1.78M → 14.34M (in $), with an average increase of 198.0% per quarter
Price Rise
![]()
In the last 1 month, VRCA stock has moved up by 22.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1024.0% return, outperforming this stock by 1105.8%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 173.4% return, outperforming this stock by 230.9%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 204.0K → -274.0K (in $), with an average decrease of 234.3% per quarter
| Organisation | Verrica Pharmaceuticals Inc |
| Headquarters | 44 West Gay Street, West Chester, PA, United States, 19380 |
| Industry | Health Technology |
| CEO | Dr. Jayson M. Rieger M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Jayson M. Rieger M.B.A., Ph.D. | President, CEO & Director |
Mr. John J. Kirby CPA | Interim Chief Financial Officer |
Mr. David Zawitz | Chief Operating Officer |
Mr. Eugene Scavola | Executive Vice President of Technical Operations |
Dr. Bradley J. Catalone MBA, Ph.D. | Head of Drug Development |
Dr. Noah L. Rosenberg M.D. | Chief Medical Officer |
Verrica Pharmaceuticals Inc share price today is $5.12 as on at the close of the market. Verrica Pharmaceuticals Inc share today touched a day high of $5.32 and a low of $4.8.
Verrica Pharmaceuticals Inc share touched a 52 week high of $13.6 on and a 52 week low of $3.28 on . Verrica Pharmaceuticals Inc stock price today i.e. is closed at $5.12,which is 62.35% down from its 52 week high and 56.10% up from its 52 week low.
Verrica Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Verrica Pharmaceuticals Inc (VRCA) shares with as little as ₹89.162 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹891.62 in Verrica Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Verrica Pharmaceuticals Inc share’s latest price of $5.12 as on November 26, 2025 at 2:29 am IST, you will get 1.9531 shares of Verrica Pharmaceuticals Inc. Learn more about
fractional shares .
Verrica Pharmaceuticals Inc stock has given -95.01% share price returns and 20.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?